Talmapimod (SCIO-469) is an orally active
Smiles: C[C@H]1CCCC=CC(=O)C2=C(CC(=O)O1)C=C(O)C=C2O |t:5|
Flumatinib effectively overcomes drug resistance of certain KIT mutants
21-heptaoxatricosan-1-yl)carbamate
Preischemic treatment with TRC160334 results in a pronounced induction of HSP70 in kidneys by 6 hours while postischemic treatment with TRC160334 results in a pronounced induction of HSP70 in kidneys by 12 hours as compared with the respective vehicle control
CTAP 1256 Talmapimod (SCIO-469) is an orallyCTAP is a potent, highly selective, and brain penetrant opioid receptor antagonist (IC50=3. 5 nM) and displays over 1200 fold selectivity over opioid (IC50=4500 nM) and somatostatin receptors. CTAP can be used for the study of L DOPA induced dyskinesia (LID). Product information CAS Number: 103429 32 9 Molecular Weight: 1104. 30 Formula: C51H69N13O11S2 Chemical Name: (2S,3R) 2 {[(4R,7S,10S,13R,16S,19R) 19 [(2R) 2 amino 3 phenylpropanamido] 10 {3